Filing Details

Accession Number:
0001209191-12-018870
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-03-19 10:45:52
Reporting Period:
2012-03-16
Filing Date:
2012-03-19
Accepted Time:
2012-03-19 10:45:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
879993 Dusa Pharmaceuticals Inc DUSA Pharmaceutical Preparations (2834) 223103129
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1205850 L Scott Lundahl C/O Dusa Pharmaceuticals, Inc.
25 Upton Drive
Wilmington MA 01887
Vp, Regulatory Affairs & Ip No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-03-16 17,500 $1.60 228,586 No 4 M Direct
Common Stock Disposition 2012-03-16 7,976 $5.75 220,610 No 4 S Direct
Common Stock Disposition 2012-03-16 1,900 $5.76 218,710 No 4 S Direct
Common Stock Disposition 2012-03-16 5,224 $5.80 213,486 No 4 S Direct
Common Stock Disposition 2012-03-16 800 $5.81 212,686 No 4 S Direct
Common Stock Disposition 2012-03-16 1,600 $5.84 211,086 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option Disposition 2012-03-16 17,500 $0.00 17,500 $1.60
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2007-03-13 2013-03-13 No 4 M Direct
Footnotes
  1. Includes Stock Awards which vest at the rate of one-quarter of the total grant on each of the first, second, third and fourth anniversaries of the date of the grant.